Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
For more information on Dr. Roth, please contact Meghan Davis, Media Specialist, University of Alabama at Birmingham. Phone: +1-205-934-3884; e-mail: email@example.com.
For more information on The American Journal of Pathology or the American Society for Investigative Pathology, please contact Dr. Audra E. Cox, Managing Editor, The American Journal of Pathology, 9650 Rockville Pike, Bethesda MD 20814. Phone: +1-301-634-7409; Fax: +1-301-634-7961; Email: firstname.lastname@example.orgMedia contact David Sampson Elsevier +1-215-239-3171 email@example.com SOURCE Elsevier